Orca-T improved 1-year survival without severe graft-vs-host disease compared with standard transplant in the Precision-T ...
The following is a summary of “Effect of radioactive iodine therapy on hematological parameters in patients with thyroid ...
Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...
A cross-sectional design was used to examine the intensity of fatigue in patients who underwent bone marrow transplantation for a hematologic malignancy, and to determine whether fatigue affected ...
According to a study published in JAMA Network Open, among patients with type 2 diabetes (T2D), the use of glucagon-like ...
No significant difference was seen in the risk for any other hematologic cancer. GLP-1 RA use was associated with ...
Panelists discuss how recent FDA approvals for bispecific antibodies in oncology, particularly for hematologic malignancies ...
Pacylex Pharmaceuticals Inc. (Pacylex) is a clinical-stage pharmaceutical company and world leader in developing N-myristoyltransferase inhibitors (NMTis) for cancer. Oral zelenirstat is under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results